HCPCS S2107
Adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g., tumor-infiltrating lymphocyte therapy) per course of treatment
Current code0 hospitals with prices
What Washington hospitals publish for this code
No Washington hospital publishes a dollar price for this code yet.
Medicare (traditional) reference
CMS publishes no national amount for this code.